Priyanka Vinod Chablani, Ali Raza Khaki, Karine Tawagi, Petros Grivas, Jeannie Hoffman-Censits, Matthew D. Galsky, Shilpa Gupta, Vadim S Koshkin, Elizabeth R. Plimack, Jonathan E. Rosenberg, Peter H. O'Donnell. "Survey-based study of treatment sequencing after first-line (1L) enfortumab vedotin/pembrolizumab (EVP) in the evolving landscape of locally advanced/metastatic (la/m) urothelial cancer (UC).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.770